POZN - US FDA OK's AstraZeneca, Pozen Inc.'s Pain Drug:
Fri Apr 30, 2010 5:19pm EDT
* Agency clears drug for U.S. market
* Vimovo includes naproxen and Nexium ingredient
* Pozen shares up more than 21 percent after-hours
WASHINGTON, April 30 (Reuters) - The U.S. Food and Drug Administration has approved AstraZeneca Plc (AZN.L) and Pozen Inc's (POZN.O) pain drug Vimovo, an agency spokeswoman told Reuters on Friday.
Vimovo is a fixed-dose combination of the anti-inflammatory drug naproxen and an immediate release version of esomeprazole, the active ingredient in AstraZeneca's acid reflux treatment Nexium.
Shares of Pozen were up more than 21 percent, or about $2.30, in after-hours trading on Friday, trading at $13.15, after earlier closing at $10.85. (Reporting by Susan Heavey; additional reporting by Ben Hirschler in London and Vidya Loganathan in Bangalore; editing by Carol Bishopric)
http://www.reuters.com/article/idCNN3015546220100430?rpc=44
POZN is currently halted...Per the Nasdaq.com website:
http://www.nasdaqtrader.com/Trader.aspx?id=TradeHalts
No time is given for resumption of trading...
There was a huge Bear Raid at 12:37 this afternoon, as the MM's took out all of the stop-loss limit orders people had in place:
POZN After-Hours Chart shows it closed at $13.15 when it was halted for "news pending":
Posts
